Lamivudine and Zidovudine
- Product NDC
- 76519-1005
- 11-digit product format
- 765191005
- Labeler code
- 76519
- Product ID
- 76519-1005_dae1ab04-6614-4083-b7b6-2612c4be0fe2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lamivudine and Zidovudine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- H.J. Harkins Company, Inc.
- Application
- ANDA079081
- Marketing category
- ANDA
- Marketing start
- 2011-12-27
- Marketing end
- 0000-00-00
- Substance
- LAMIVUDINE; ZIDOVUDINE
- Active strength
- 150 mg/1; mg/1
- Pharmacologic classes
- Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 76519-1005-6 | Lamivudine and Zidovudine | 6 in 1 BOTTLE | TABLET, FILM COATED | 6 | | 1 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| LAMIVUDINE | ACTIVE INGREDIENT | 2T8Q726O95 | LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.] | 1 | |
| ZIDOVUDINE | ACTIVE INGREDIENT | 4B9XT59T7S | LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.] | 1 | |
| LAMIVUDINE | ACTIVE MOIETY | 2T8Q726O95 | LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.] | 1 | |
| ZIDOVUDINE | ACTIVE MOIETY | 4B9XT59T7S | LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.] | 1 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.] | 1 | |
| HYPROMELLOSE 2910 (3 MPA.S) | INACTIVE INGREDIENT | 0VUT3PMY82 | LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.] | 1 | |
| HYPROMELLOSE 2910 (6 MPA.S) | INACTIVE INGREDIENT | 0WZ8WG20P6 | LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.] | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.] | 1 | |
| POLYETHYLENE GLYCOL 400 | INACTIVE INGREDIENT | B697894SGQ | LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.] | 1 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.] | 1 | |
| SODIUM STARCH GLYCOLATE TYPE A POTATO | INACTIVE INGREDIENT | 5856J3G2A2 | LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.] | 1 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 76519-1005 | LAMIVUDINE AND ZIDOVUDINE TABLET, FILM COATED [H.J. HARKINS COMPANY, INC.] | 1 | Legacy NDC, 1 package rows | 20120626_fc2d6065-7806-457c-82e1-04bb19e57b8c.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 76519-1005-6 | 76519100506 | 6 in 1 BOTTLE | Historical |